Fe-PM significantly improved iron status in children by 4 mo compared with Control-PM. This study demonstrated that feeding Fe-PM is an efficacious approach to improve iron status in school-age children and it should be further evaluated for effectiveness in a broader population context. This trial was registered at clinicaltrials.gov as NCT02152150.

Nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk for future cardiovascular disease (CVD), including coronary heart disease (CHD), heart failure, stroke, and arrhythmia. 1 CVD is one of the most common causes of death in patients with NAFLD; therefore, it is essential that hepatologists are aware of CVD risk factors and perform CVD risk stratification in this population. This brief review provides a pragmatic guide of CVD in NAFLD with a focus on CHD.

This study demonstrates the potential benefit of LDLT, particularly with maternal grafts, for pediatric liver transplant recipients on multiple clinical parameters over long-term follow-up.

Despite smaller graft sizes, outcomes of adult LDLT using LLG are comparable to right lobe grafts transplants. Left lobes can provide an important resource in an era of severe organ shortages, and these data should serve to allay the concerns of the transplant community in the United States.